Malnutrition in Cirrhosis: Contribution and Consequences of Sarcopenia on Metabolic and Clinical Responses

被引:195
作者
Periyalwar, Pranav [1 ,2 ]
Dasarathy, Srinivasan [1 ,3 ]
机构
[1] Cleveland Clin, Lerner Res Inst, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA
[2] Metrohlth Med Ctr, Dept Gastroenterol, Cleveland, OH 44109 USA
[3] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA
关键词
Malnutrition; Cirrhosis; Sarcopenia; Metabolism; QUALITY-OF-LIFE; MINIMAL HEPATIC-ENCEPHALOPATHY; SUBJECTIVE GLOBAL ASSESSMENT; STAGE LIVER-DISEASE; PROTEIN-CALORIE MALNUTRITION; CHAIN AMINO-ACIDS; INTRAHEPATIC PORTOSYSTEMIC SHUNT; BIOELECTRICAL-IMPEDANCE ANALYSIS; SKELETAL-MUSCLE HYPERTROPHY; X-RAY ABSORPTIOMETRY;
D O I
10.1016/j.cld.2011.12.009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Malnutrition is the most common, reversible complication of cirrhosis that adversely affects survival, response to other complications, and quality of life. Sarcopenia, or loss of skeletal muscle mass, and loss of adipose tissue and altered substrate use as a source of energy are the 2 major components of malnutrition in cirrhosis. Current therapies include high protein supplementation especially as a late evening snack. Exercise protocols have the potential of aggravating hyperammonemia and portal hypertension. Recent advances in understanding the molecular regulation of muscle mass has helped identify potential novel therapeutic targets including myostatin antagonists, and mTOR resistance.
引用
收藏
页码:95 / +
页数:38
相关论文
共 192 条
[31]   Branched-chain amino acid enriched supplements as therapy for liver disease [J].
Charlton, M .
JOURNAL OF NUTRITION, 2006, 136 (01) :295S-298S
[32]   PREDICTION OF MUSCLE AND REMAINING TISSUE PROTEIN IN MAN [J].
CHINN, KSK .
JOURNAL OF APPLIED PHYSIOLOGY, 1967, 23 (05) :713-&
[33]   RELATIONSHIP OF MUSCLE PROTEIN TO OTHER COMPONENTS OF FAT-FREE MASS [J].
CHINN, KSK ;
HANNON, JP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1966, 211 (04) :993-&
[34]   Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: Results of a pilot randomized controlled clinical trial [J].
Conchillo, M ;
de Knegt, RJ ;
Payeras, M ;
Quiroga, J ;
Sangro, B ;
Herrero, JI ;
Castilla-Cortazar, I ;
Frystyk, J ;
Flyvbjerg, A ;
Yoshizawa, C ;
Jansen, PLM ;
Scharschmidt, B ;
Prieto, J .
JOURNAL OF HEPATOLOGY, 2005, 43 (04) :630-636
[35]   Vitamin D replacement for cirrhosis-related bone disease [J].
Crawford, Bronwyn A. ;
Labio, Eternity D. ;
Strasser, Simone I. ;
McCaughan, Geoffrey W. .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (12) :689-699
[36]   Interorgan ammonia trafficking in liver disease [J].
Damink, Steven W. M. Olde ;
Jalan, Rajiv ;
Dejong, Cornelius H. C. .
METABOLIC BRAIN DISEASE, 2009, 24 (01) :169-181
[37]   Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat [J].
Dasarathy, S ;
Dodig, M ;
Muc, SM ;
Kalhan, SC ;
McCullough, AJ .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 287 (06) :G1124-G1130
[38]   Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat [J].
Dasarathy, S ;
Mullen, KD ;
Conjeevaram, HS ;
Kaminsky-Russ, K ;
Wills, LA ;
McCullough, AJ .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (09) :1936-1942
[39]  
Dasarathy S, 2009, HEPATOLOGY
[40]   Altered expression of genes regulating skeletal muscle mass in the portacaval anastamosis rat [J].
Dasarathy, Srinivasan ;
Muc, Sean ;
Hisamuddin, Kola ;
Edmison, John M. ;
Dodig, Milan ;
McCullough, Arthur J. ;
Kalhan, Satish C. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 292 (04) :G1105-G1113